Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence of atherogenic dyslipidemia, related factors and level of lipid control in the general population of Galicia. GALIPEMIAS study
Carlos Názara; Rosa M. Argüeso; Juan Pedro-Botet; Xavier Pintó; Jesús Millán; Marta Pena Seijo; Pablo A. Fernández; M. Eugenia Ameneiros; Alberto del Alamo; Avelino Rodríguez; José Antonio Díaz-Peromingo; María Rosa Vázquez Freire; Javier Muñiz; Teresa R. Pérez-Castro; José Luis Díaz-Díaz; Antonio Pose Reino;
Clin Investig Arterioscler. 2023;35:178-84
How to achieve LDL cholesterol goals with the funding criteria for new lipid-lowering drugs?
Antón González-Guerrero; Elisenda Climent; David Benaiges; Juan Pedro Botet;
Clin Investig Arterioscler. 2025;37:
Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study
Àlex Vila; Estel Pons; Patricia Trinidad García; Daniel Vidal; Sara López; Armand Grau;
Clin Investig Arterioscler. 2023;35:272-9